熱門資訊> 正文
TFF Pharmaceuticals将结束运营
2024-11-15 05:23
- TFF Pharmaceuticals (NASDAQ:TFFP) announced, on Thursday, that the company has terminated its employees and will wind down its operations.
- The board of directors appointed Craig R. Jalbert as the company’s CEO, President, Chief Financial Officer, Treasurer and Secretary, and sole member of the board.
More on TFF Pharmaceuticals
- TFF Pharmaceuticals enters pact for dry powder mRNA-based Covid treatment
- Seeking Alpha’s Quant Rating on TFF Pharmaceuticals
- Historical earnings data for TFF Pharmaceuticals
- Financial information for TFF Pharmaceuticals
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。